LETTER TO THE EDITOR Aldolase Determination
To the Editor:
In their publication, Aldolase II, Clinical Chemistry 15, 349 (1969) , the authors Patrick V. C. Pinto, Alex Kaplan, and Paul A. Van Dreal express two reservations against the BMC test kit for the UV-determination of Aldolase: (1) The operating instruction did not mention that a preincubation period is required in order to eliminate interferences by other dehydrogenases.
(2) Aldolase activity was not the rate limiting factor since the amount of triosephosphate isomerase was insufficient.
We wish to comment as follows: (1) Acad. Press, New York, 1965, p 729, the minimum requirement is 2.0 1.11. per test, which represents a thousand-fold excess over the recommended upper limitof aldolase activity in the sample.For kineticreasons (H. U. Bergmeyer, ibid, p. 11) a thousand-fold excess of indicator enzyme is essential for coupled reaction-systems with three steps, in order to assure that the first reaction of the system is rate limiting.
The two reasons for possible incorrect results with the Boehringer Mannheim material were eliminated before the above mentioned paper was published. Dr. Pinto was made aware of this prior to the publication of his paper.
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